逆转录酶
慢病毒
逆转录病毒
病毒学
生物
分子生物学
病毒
聚合酶链反应
基因
遗传学
病毒性疾病
作者
Lakshmi Sastry,Yi Xu,Lisa Duffy,Steven E. Koop,Aparna Jasti,Holger Roehl,Doug J. Jolly,Kenneth Cornetta
出处
期刊:Human Gene Therapy
[Mary Ann Liebert, Inc.]
日期:2005-10-01
卷期号:16 (10): 1227-1236
被引量:32
标识
DOI:10.1089/hum.2005.16.1227
摘要
The product-enhanced reverse transcriptase (PERT) assay has been used to detect reverse transcriptase (RT) activity associated with retroviruses. Although the PERT assay has been proposed as a method for detection of replication-competent retrovirus (RCR) and lentivirus (RCL), it has not been rigorously compared with existing methods for RCR and RCL detection. We have assessed the PERT assay for detection of RCL and RCR that may contaminate lentiviral and retroviral vectors and compared it with published methods for RCL (p24 gag ELISA/gag PCR) and RCR (S+/L−) detection. Our results suggest that the PERT assay is as sensitive as p24 gag ELISA and gag PCR for detection of replication-competent HIV-1 in an RCL detection assay. Comparison of detection of replication-competent retroviruses, GALV and RD114, by extended S+/L− and PERT assays indicates that both assays can detect 1 IU of each virus. Our findings suggest that the PERT assay can be used for RCL and RCR testing of a variety of retroviral vectors regardless of the structure, sequence, and envelope of the vectors.
科研通智能强力驱动
Strongly Powered by AbleSci AI